原文 | 美式英語 |
---|---|
頁(從 - 到) | 89-90 |
期刊 | Gynecologic Oncology |
卷 | 159 |
DOIs | |
出版狀態 | 已出版 - 2020 |
ENGOT-ov43/keylynk-001: A phase III, placebo- and active-controlled trial of pembrolizumab plus chemotherapy with olaparib maintenance for first-line treatment of advanced BRCA-nonmutated epithelial ovarian cancer
R. L. Coleman, K. Fujiwara, J. Sehouli, V. Salutari, P. Zola, R. Madry, J. Korach, P. Pautier, D. Cibula, S. Lheureux, K. Hasegawa, B. G. Kim, Chyong-Huey Lai, A. Gonzalez-Martinez, Q. Liu, S. Keefe, M. Puglisi, S. Topuz, B. J. Monk, R. C. Arend
研究成果: 期刊稿件 › 文章 › 同行評審